Founded in April 2013, Suzhou Yuewei is located in the 'Jiangsu Province Medical Device Technology Industrial Park' in the Science and Technology City of Suzhou High-tech District. It is a high-tech biotech company engaged in the research and development, production, and sales of gene diagnosis and detection reagents. The company is equipped with modern standardized GMP production workshops for diagnostic reagents, quality inspection workshops, and a scientific research and development platform, enabling it to fully independently research, develop, and produce gene diagnosis and detection reagents at international standards.
Relying on two major scientific research platforms, the 'China Suzhou International Biomedical Center' and the 'Suzhou Institute of Industrial Technology of Zhejiang University', the company has strong R&D capabilities. Its core team members include multiple Ph.D. and Master's degree holders from renowned domestic universities such as Peking University, Peking Union Medical College, the Chinese Academy of Sciences, and Zhejiang University, as well as top industry experts.
At present, the company's main business is the development and production of a series of products including forensic DNA typing identification reagents, genetic disease gene diagnosis reagents, chromosomal numerical abnormality gene diagnosis reagents, tumor gene mutation detection reagents, and gene detection and identification reagents for viral and bacterial diseases. Among them, the 'Forensic Science Human Fluorescent Labeled STR Multiplex Amplification Detection Reagent' has obtained China Public Security Product Certification. The acquisition of this certification marks that the company's products will formally enter the market and be widely applied in various aspects of life such as disease prevention, gene diagnosis, and personalized treatment.
To enhance the company's R&D level, we jointly invested with the Suzhou Institute of Industrial Technology of Zhejiang University to establish the 'Joint R&D Center for Gene Testing', which has an R&D area of approximately 700 square meters. In terms of hardware equipment, it possesses large-scale instruments each valued at over one million yuan, such as ABI3500, ABI 3130, ABI 3730xl, and ABI310 gene sequencers, three sets of ABI 7900ht fluorescence quantitative systems, more than 10 PCR instruments, gel imaging systems, automated workstations, ultra-clean workbenches, etc. The center's hardware equipment can fully meet the R&D and industrialization needs of our series of products.
In terms of marketing model, we have established a marketing model combining 'direct sales + channels' and 'traditional + IoT-enabled'. The direct sales team has successfully covered markets in Beijing, Shanghai, Guangzhou, Hangzhou, Shenyang, Chengdu, and Changsha. Internationally, multiple countries have expressed intention to reach cooperation agreements with the company.
Facing future opportunities and development, Suzhou Yuewei will take it as its mission to track the development trends of modern molecular medicine and gene diagnosis and to research and reserve forward-looking gene diagnosis reagents. It will seek development through innovation and, with strong technical strength, excellent product performance, a high-quality R&D team, first-class pre-sales and after-sales service, and a strict and scientific modern enterprise management system, strive to become a leading player in the domestic gene testing industry.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows